Sign in

CIK 0000310158

  • Large accelerated filer

Merck & Co., Inc.

Sign in to watch
Ticker
MRK
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
EIN
221918501
Phone
+1 908-740-4000
Business address
126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
Former names
Merck & Co. Inc., SCHERING PLOUGH CORP
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Open-market sale President, U.S. Market sold 2,081 shares at $102.38 ($213,061)
  4. 4 Open-market sale EVP&Pres, Merck Animal Heallth sold 43,823 shares at $105.03 ($4,602,668)
  5. 4 Derivatives Options or other derivatives
  6. 4 Exercise or conversion President, U.S. Market acquired 915 shares (option exercise)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale EVP, Chief HR Officer sold 4,250 shares at $109.01 ($463,293)
  12. 4 Exercise or conversion Chief Marketing Officer acquired 36,901 shares (option exercise)
  13. 4 Open-market sale EVP, Chief HR Officer sold 4,500 shares at $105.49 ($474,701)
  14. 4 Open-market sale President, Human Health Int?l sold 89 shares at $107.37 ($9,556)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market buy President, Human Health Int?l bought 409 shares at an average $108.40 ($44,336)
  20. 4 Derivatives Options or other derivatives

Page 12 of 99 · 1,973 filings